Goldman Sachs Group Inc Ptc Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 822,441 shares of PTCT stock, worth $37.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
822,441
Previous 791,164 3.95%
Holding current value
$37.2 Million
Previous $24.2 Million 26.12%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$30.39 - $37.66 $950,508 - $1.18 Million
31,277 Added 3.95%
822,441 $30.5 Million
Q2 2024

Aug 13, 2024
BUY
$24.69 - $40.12 $7.68 Million - $12.5 Million
311,143 Added 64.82%
791,164 $24.2 Million
Q1 2024

May 15, 2024
SELL
$24.15 - $31.95 $1.12 Million - $1.48 Million
-46,473 Reduced 8.83%
480,021 $14 Million
Q4 2023

Feb 13, 2024
BUY
$18.07 - $29.37 $3.37 Million - $5.48 Million
186,608 Added 54.9%
526,494 $14.5 Million
Q3 2023

May 14, 2024
SELL
$22.41 - $41.99 $4.18 Million - $7.84 Million
-186,608 Reduced 35.44%
339,886 $7.62 Million
Q3 2023

Nov 14, 2023
SELL
$22.41 - $41.99 $1.94 Million - $3.63 Million
-86,346 Reduced 20.26%
339,886 $7.62 Million
Q2 2023

May 14, 2024
SELL
$40.4 - $59.1 $1.07 Million - $1.56 Million
-26,450 Reduced 5.84%
426,232 $17.3 Million
Q2 2023

Aug 14, 2023
SELL
$40.4 - $59.1 $1.07 Million - $1.56 Million
-26,450 Reduced 5.84%
426,232 $17.3 Million
Q1 2023

May 14, 2024
SELL
$38.16 - $48.86 $3.07 Million - $3.93 Million
-80,352 Reduced 15.07%
452,682 $21.9 Million
Q1 2023

May 11, 2023
SELL
$38.16 - $48.86 $3.07 Million - $3.93 Million
-80,352 Reduced 15.07%
452,682 $21.9 Million
Q4 2022

May 14, 2024
BUY
$33.53 - $54.79 $923,952 - $1.51 Million
27,556 Added 5.45%
533,034 $20.3 Million
Q4 2022

Feb 13, 2023
BUY
$33.53 - $54.79 $923,952 - $1.51 Million
27,556 Added 5.45%
533,034 $20.3 Million
Q3 2022

May 14, 2024
BUY
$41.85 - $53.85 $389,121 - $500,697
9,298 Added 1.87%
505,478 $25.4 Million
Q3 2022

Nov 10, 2022
BUY
$41.85 - $53.85 $389,121 - $500,697
9,298 Added 1.87%
505,478 $25.4 Million
Q2 2022

May 14, 2024
SELL
$25.6 - $45.23 $776,038 - $1.37 Million
-30,314 Reduced 5.76%
496,180 $19.9 Million
Q2 2022

Aug 15, 2022
BUY
$25.6 - $45.23 $6.85 Million - $12.1 Million
267,773 Added 117.24%
496,180 $19.9 Million
Q1 2022

May 16, 2022
SELL
$33.33 - $44.6 $9.96 Million - $13.3 Million
-298,926 Reduced 56.69%
228,407 $8.52 Million
Q4 2021

Feb 14, 2022
BUY
$35.36 - $41.86 $10.6 Million - $12.5 Million
299,114 Added 131.06%
527,333 $21 Million
Q3 2021

Nov 10, 2021
BUY
$37.01 - $44.74 $8.45 Million - $10.2 Million
228,219 New
228,219 $8.49 Million

Others Institutions Holding PTCT

# of Institutions
221
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.24B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email